APTA: Aptamer Group PLC - Summary | Jitta

Aptamer Group PLC

LON:APTA

Price
£0.01
Loss Chance
57.9%
1.46JITTA SCORE
100.00%Over Jitta Line
Jitta Ranking
625 / 877
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (37)
Recent Business Performance (46)
Financial Strength (38)
Return to Shareholders (0)
Competitive Advantage (31)
Jitta Signs
Recent Business PerformanceEarning Growth Last Year
Cash Conversion CycleLess than 60 days
Revenue and EarningEarning loss detected in 2025
Operating MarginInconsistent
New Share IssuedMore than 50% in 5 years
CapExVery High
SG&A to SalesIncreasing
Key Stats
Jitta Score
Jitta Line
1.46
100.00%
1.95
101.42%
3.19
127.39%
Biotechnology
0.34
100.00%
2.08
100.00%
1.85
100.00%
COMPANY DESCRIPTION
Aptamer Group PLC, together with its subsidiaries, provides synthetic binders for research, diagnostics, and therapeutics in the United Kingdom, rest of Europe, the United States, and internationally. The company offers Optimer, a platform that enables the discovery and development of optimized DNA and RNA aptamers, which can bind to target molecules. Its platform is used in research reagent and analytical, bioprocessing, diagnostic, cosmetic and consumer health, and therapeutic applications. The company serves pharmaceutical, diagnostic, and bioprocessing companies. It has collaborations with Unilever, Neuro-Bio, the University of Glasgow, AstraZeneca, and Invizius. Aptamer Group PLC was founded in 2008 and is headquartered in York, the United Kingdom.